应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DRTSW Alpha Tau Medical Warrant
盘前交易 01-26 06:59:31 EST
0.9238
-0.0562
-5.73%
最高
1.00
最低
0.8000
成交量
6.73万
今开
0.8400
昨收
0.9800
日振幅
20.41%
总市值
6,502万
流通市值
6,502万
总股本
7,038万
成交额
6.30万
换手率
0.10%
流通股本
7,038万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Alpha Tau Medical将在ASCO GI 2026研讨会上公布两项新积极成果 展示蒙特利尔胰腺癌Alpha Dart®研究的免疫保护与高疾病控制率
美股速递 · 01-06
Alpha Tau Medical将在ASCO GI 2026研讨会上公布两项新积极成果 展示蒙特利尔胰腺癌Alpha Dart®研究的免疫保护与高疾病控制率
Alpha Tau获得FDA批准启动局部复发前列腺癌患者试验
美股速递 · 2025-12-02
Alpha Tau获得FDA批准启动局部复发前列腺癌患者试验
Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者
美股速递 · 2025-09-02
Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者
加载更多
公司概况
公司名称:
Alpha Tau Medical Warrant
所属市场:
NASDAQ
上市日期:
--
主营业务:
Alpha Tau Medical Ltd.是一家于2016年在以色列成立的公司。该公司是一家临床阶段的肿瘤治疗公司,专注于利用先天的相对生物有效性和短程α颗粒作为实体瘤的局部放射治疗。该公司专有的Alpha DaRT技术旨在利用alpha粒子的特定治疗特性,同时旨在克服甚至利用alpha辐射范围有限的传统缺点,以获得潜在利益。该公司已经在世界各地的临床地点进行了多项临床试验,评估并继续评估Alpha DaRT技术治疗浅表病变,即皮肤、头部或颈部肿瘤的可行性、安全性和有效性。
发行价格:
--
{"stockData":{"symbol":"DRTSW","market":"US","secType":"STK","nameCN":"Alpha Tau Medical Warrant","latestPrice":0.9238,"timestamp":1769202000000,"preClose":0.98,"halted":0,"volume":67293,"delay":0,"changeRate":-0.05734693877551023,"floatShares":70380571,"shares":70380571,"eps":-0.5213,"marketStatus":"盘前交易","change":-0.0562,"latestTime":"01-26 06:59:31 EST","open":0.84,"high":1,"low":0.8,"amount":63006.543569,"amplitude":0.204082,"askPrice":1.47,"askSize":200,"bidPrice":0.3696,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.5213,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769437800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9238,"volumeRatio":0.7916227491498267},"requestUrl":"/m/hq/s/DRTSW","defaultTab":"news","newsList":[{"id":"1152568891","title":"Alpha Tau Medical将在ASCO GI 2026研讨会上公布两项新积极成果 展示蒙特利尔胰腺癌Alpha Dart®研究的免疫保护与高疾病控制率","url":"https://stock-news.laohu8.com/highlight/detail?id=1152568891","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152568891?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:08","pubTimestamp":1767708521,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical宣布,其即将在ASCO GI 2026研讨会上展示的两项研究取得了新的积极结果。这些成果重点揭示了Alpha Dart®蒙特利尔胰腺癌研究中体现的免疫保护特性与卓越疾病控制效果。\n研究数据显示,该疗法在维持患者免疫系统功能的同时,实现了较高的疾病控制水平。这一突破为胰腺癌治疗领域提供了新的方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTSW","BK4082","DRTS"],"gpt_icon":0},{"id":"1160292703","title":"Alpha Tau获得FDA批准启动局部复发前列腺癌患者试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1160292703","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160292703?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:02","pubTimestamp":1764684124,"startTime":"0","endTime":"0","summary":"Alpha Tau获得FDA批准,启动针对局部复发前列腺癌患者的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DRTS","DRTSW"],"gpt_icon":0},{"id":"1151041494","title":"Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1151041494","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151041494?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:31","pubTimestamp":1756816268,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical成功治疗美国多中心胰腺癌临床试验首例患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","DRTSW","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphatau.com","stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":1.8869},{"period":"3month","weight":1.7348},{"period":"6month","weight":2.6399},{"period":"1year","weight":1.6394},{"period":"ytd","weight":1.7171}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alpha Tau Medical Ltd.是一家于2016年在以色列成立的公司。该公司是一家临床阶段的肿瘤治疗公司,专注于利用先天的相对生物有效性和短程α颗粒作为实体瘤的局部放射治疗。该公司专有的Alpha DaRT技术旨在利用alpha粒子的特定治疗特性,同时旨在克服甚至利用alpha辐射范围有限的传统缺点,以获得潜在利益。该公司已经在世界各地的临床地点进行了多项临床试验,评估并继续评估Alpha DaRT技术治疗浅表病变,即皮肤、头部或颈部肿瘤的可行性、安全性和有效性。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.908076},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.107077},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.128779},{"month":4,"riseRate":0,"avgChangeRate":-0.255678},{"month":5,"riseRate":1,"avgChangeRate":0.239851},{"month":6,"riseRate":0.5,"avgChangeRate":0.067245},{"month":7,"riseRate":0.25,"avgChangeRate":-0.069378},{"month":8,"riseRate":0.5,"avgChangeRate":0.069113},{"month":9,"riseRate":0.5,"avgChangeRate":0.006417},{"month":10,"riseRate":0,"avgChangeRate":-0.138065},{"month":11,"riseRate":0.75,"avgChangeRate":0.165827},{"month":12,"riseRate":0,"avgChangeRate":-0.159553}],"exchange":"NASDAQ","name":"Alpha Tau Medical Warrant","nameEN":"Alpha Tau Medical Warrant"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alpha Tau Medical Warrant(DRTSW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alpha Tau Medical Warrant(DRTSW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alpha Tau Medical Warrant,DRTSW,Alpha Tau Medical Warrant股票,Alpha Tau Medical Warrant股票老虎,Alpha Tau Medical Warrant股票老虎国际,Alpha Tau Medical Warrant行情,Alpha Tau Medical Warrant股票行情,Alpha Tau Medical Warrant股价,Alpha Tau Medical Warrant股市,Alpha Tau Medical Warrant股票价格,Alpha Tau Medical Warrant股票交易,Alpha Tau Medical Warrant股票购买,Alpha Tau Medical Warrant股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alpha Tau Medical Warrant(DRTSW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alpha Tau Medical Warrant(DRTSW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}